Scientists hunt for clues in the blood to unlock mysterious brain lymphoma

This study compares blood samples from 20 people with primary central nervous system lymphoma (a rare brain cancer) to samples from people with other types of lymphoma and healthy volunteers. Researchers will look at small molecules (metabolites) and immune cells to find differences that may help diagnose or understand the disease better. No new treatment is given; participants only provide samples and have regular check-ups.